The launch of the drug is welcome news for diabetic patients with insulin resistance, which happens to be a common problem in India with every four out of ten diabetic patients showing insulin resistance in India.from Moneycontrol Business News https://ift.tt/nrLgto8
No comments:
Post a Comment